This study is a phase I clinical study evaluating LBL-003 monotherapy in patients with advanced solid tumors in dose escalation. The overall design of the study is shown in the figure below. The purpose of the LBL-003 single-dose escalation study in subjects with advanced solid tumors is to evaluate the safety and tolerability of monotherapy to determine the MTD (or MAD) and clinically recommended doses of LBL-003 monotherapy.
A phase I clinical study evaluating LBL-003 in the treatment of subjects with advanced solid tumors .